Galina Karpenko
Obstetrics & Gynecology · New York, NYNPI 1639237100
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 261 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 21.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,364 and has fallen 51.9% since, to $656 in 2025. Among obstetrics & gynecology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 261 payments — averaging $22.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Ferring Pharmaceuticals Inc.$606
- Sumitomo Pharma America, Inc.$591
- Avion Pharmaceuticals$418
- Pfizer$397
- Mayne Pharma Commercial LLC$388
- plus $2K from 19 others
What the payments were for
- Food & beverage$5,754100%
- Education$110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 51 | $1,214 |
| Ferring Pharmaceuticals Inc. | 22 | $606 |
| Sumitomo Pharma America, Inc. | 25 | $591 |
| Avion Pharmaceuticals | 22 | $418 |
| Pfizer | 20 | $397 |
| Mayne Pharma Commercial LLC | 22 | $388 |
| Astellas Pharma US Inc | 15 | $378 |
| Myovant Sciences Inc. | 14 | $288 |
| Evofem Biosciences, Inc. | 8 | $169 |
| Millicent US Inc | 9 | $159 |
| Exeltis, USA Inc. | 7 | $145 |
| Lupin Inc. | 7 | $136 |
| Daiichi Sankyo Inc. | 6 | $122 |
| Agile Therapeutics, Inc. | 6 | $120 |
| Vertical Pharmaceuticals, LLC | 5 | $100 |
| Myriad Women's Health, Inc. | 2 | $97 |
| Mission Pharmacal Company | 4 | $79 |
| Scynexis, Inc. | 2 | $62 |
| Ascend Therapeutics US, LLC | 3 | $61 |
| EMD Serono, Inc. | 3 | $57 |
| Coopersurgical, Inc. | 2 | $56 |
| Therapeuticsmd, Inc. | 2 | $45 |
| Duchesnay USA Incorporated | 2 | $43 |
| Hologic Sales And Service, LLC | 1 | $19 |
| Virtus Pharmaceuticals LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orilissa$121
How this compares
$5,766 in reported general payments places this provider in the 90th percentile of 2,673 obstetrics & gynecology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol (Twice Weekly)Estradiol | 21 | $2,468 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in New York
- Mary PolanNew York$862K
- Steven GoldsteinNew York$551K
- Veronica LernerNew York$368K
- Lisa EngNew York$219K
- Rachel MaschNew York$187K
- Amy PollackNew York$184K
- Jian Qun HuangNew York$160K
- Carolyn WesthoffNew York$143K
- Melanie MarinNew York$123K
- Amitasrigowri MurthyNew York$117K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.